SB 1169
Senate·20th Congress·Filed Aug 11, 2025
Drugs and Medicines Price Regulatory Board
An Act Establishing the Drug Price Regulatory Board to Regulate the Prices of Drugs and Medicines in the Philippines Amending for the Purpose Republic Act No. 9502, Otherwise Known as the Universally Accessible Cheaper and Quality Medicines Act of 2008 and for Other Purposes
In plain language
The bill creates a Drug Price Regulatory Board under the Department of Health that can set maximum retail prices for medicines, require labels to show those prices, and use a ₱500 million trust fund for parallel imports and other cost‑cutting measures. It also gives the Board powers to fine or suspend licenses of companies that overprice drugs and to mandate that large distributors allocate at least 15 % of their purchases to a designated generic product. The law would take effect 15 days after publication.
HealthConsumer ProtectionPublic Works and Infrastructure
Automated summary by BatasWatch. It may miss nuance — read the bill text before citing it.
Author · Senator
Subjects
Universal Health CareMedicines/DrugsCheaper Medicines
Official sources
Spot something wrong?
Printed from CivicSync PH: https://civicsync-ph-gamma.vercel.app/bills/SBN-1169. Status changes over time; check the link for the latest.
SBN-1169 · Sources: BetterGov Open Congress, BatasWatch